The objective of the present study was to assess whether the FSS is a valid and reproducible instrument to evaluate fatigue in PD patients in Brazil.
MetHODS
This was an observational, cross-sectional study that evaluated patients with the clinical diagnosis of PD, according to the PD Society Brain Bank criteria for idiopathic PD (UK-PDSBB) 8 . Patients with other neurological disorders, previous neurosurgery and dementia were excluded. The patients were recruited from the university medical care center from October 2010 through December 2010. All participants were evaluated through the Mini-Mental State Examination (MMSE) 9 , and they were expected to achieve a score equals to, or above, 20, if they had no schooling and equals to, or above, 24 for subjects with some level of schooling. PD symptoms were evaluated through the Unified Parkinson's Disease Rating Scale (UPDRS) 10 (subscales I, II and III) and Hoehn and Yahr modified scale (HY) 11 , while depressive symptoms were assessed using the Beck Depression Inventory (BDI) 12 .
Quality of life was evaluated through the PD Quality of Life Questionnaire (PDQ-39) 13 . Also, demographic data were collected. The patients completed the Brazilian version of the Fatigue Severity Scale (FSS-BR). In the present study, backtranslation of the FSS was not necessary, since Doctor Krupp, which is the holder of the copyright of the original Englishlanguage scale 7 , granted us the rights to use a Portugueselanguage version of the FSS that was developed by her group. After this version, it was applied to a small sample of patients with PD, in order to identify terms or situations that could not be applied to Brazilians. Since there were no problems related to this scale, it was not necessary to make any changes to the questions. The present study was approved by the Ethics Committee of the Federal University of Bahia. All subjects provided informed consent.
The construct validity of the FSS-BR was evaluated based on the correlation of the FSS-BR score with the PDQ-39, HY modified scale, UPDRS, and BDI.
In order to determine the reliability of the FSS-BR, the scale was applied on two occasions, two weeks apart, by two well-trained interviewers. The assessments were denominated interview 1 (on both occasions to evaluate intra-observer reliability) and interview 2 (to evaluate inter-observer reliability). Interviews were conducted independently by the evaluators with a 30-minute interval between them.
Statistical analysis
Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) software, version 16.0, for Windows. Descriptive statistics were used as required. Since data were ordinal, nonparametric statistical analysis was used. The internal consistency of the scale was assessed using Cronbach's coefficient alpha.
The construct validity of the FSS-BR in relation to the PDQ-39 was determined using Spearman's correlation coefficient, like the correlation of the FSS-BR with disease severity through the HY and UPDRS, and with depressive symptoms through the BDI.
The FSS-BR test-retest reproducibility was determined using the intraclass correlation coefficient (ICC), as well as the Wilcoxon's test, to detect differences between days 1 and 2. The concordance between days 1 and 2 and interviews 1 and 2 was visually assessed using Bland and Altman plots. Statistical significance was set at p<0.05.
reSUltS
Thirty patients were included in the study, and most of them were classified as having HY stages 1 and 2 (Table 1) . No significant differences were found between the sex in age, disease duration, MMSE, UPDRS, HY, FSS-BR, PDQ-39 total score, and BDI. The clinical profile of the patients is depicted in Table 1 . All patients were taking anti-Parkinsonian drugs, and none of the patients was excluded from the study.
The median for the FSS-BR was 4.4, ranging from 1.3 to 7. Regarding the FSS test time, there was no statistical difference between days 1 and 2 (p>0.05). The mean test times on days 1 and 2 were 4 and 3.5 minutes, respectively.
In the comparison between days 1 and 2, there were no significant differences in the FSS-BR (p=0.67), and the comparison between interviewers 1 and 2 showed no significant differences in the FSS-BR either (p=0.22).
The FSS-BR was strongly reproducible, with a significant correlation with the PDQ-39 domains and total score (0.38<r<0.93). Significant correlations were found between the FSS-BR score and the HY, UPDRS and BDI (Table 2) , and excellent internal consistency was demonstrated by a Cronbach's coefficient alpha of 0.95. The ICC between days 1 and 2 was 0.91 (p<0.01), and the Bland and Altman plots showed good test-retest concordance for the FSS-BR between days 1 and 2 (p=0.98), and between interviews 1 and 2 (p=0.16), as seen in Figure. 
DiScUSSiON
Since most scales and questionnaires have been developed in English-speaking countries, a validation process is required before these instruments can be used in other countries. Therefore, for these instruments to be considered appropriate for clinical or research use, it is necessary to evaluate their reproducibility 14 .
The results of the present study demonstrated that the FSS-BR is valid and reproducible to use in assessing the fatigue of Brazilian patients with PD.
In the present study, the construct validity of the FSS-BR was shown by the strong and significant correlation of its score with the domain scores and overall score of the PDQ-39 and with the BDI score, as well as a moderate correlation with the HY and UPDRS scores. The FSS-BR shows excellent internal consistency, demonstrated by a Cronbach' s coefficient alpha of 0.95.
The absence of a statistically significant test-retest difference, together with the high ICC value of 0.91 and excellent internal consistency expressed by a Cronbach's coefficient alpha of 0.95, demonstrates the reproducibility of the FSS-BR. The reproducibility of the FSS-BR was also visually assessed using Bland and Altman plots, which showed that the bias ratio (difference between days 1 and 2) was very close to zero; this demonstrated good concordance between days 1 and 2, and between interviews 1 and 2. Recently, a group of Brazilian researchers translated and validated the Parkinson's Fatigue Scale, which has shown an excellent internal consistency and correlation with the female sex, dysthymia, severity of depression, and daily somnolence 15 .
Regarding the FSS-BR test time, there was no statistical difference between days 1 and 2, although the test time on day 2 was shorter. We believe this minimal difference could be due to the fact that patients had better comprehension of the questions. The length of time was good, compared to the time required to administer the other questionnaire used in Brazil 16 . The median for the FSS-BR was 4.4, ranging from 1.3 to 7. For the sake of comparison, similar data from the original study by Krupp and Pollina 7 , who evaluated the severity of fatigue, resulted in average values of 4.6 in PD patients.
The use of the FSS-BR could contribute more specifically to assess the impact of an intervention (physical and pharmacological) on the fatigue of patients with PD. Moreover, 
